Leadership Team

Our executive team combines successful track records in reproductive health with cross-functional, global expertise to help make a significant difference in the lives of women.

Ernest Loumaye, MD, PhD

Co-Founder & CEO – ObsEvaMember, ObsEva Board of Directors

More info

Tim Adams

Chief Financial Officer

More info

Elizabeth Garner, MD, MPH

Chief Medical Officer

More info

Jean-Pierre Gotteland, PhD

Chief Scientific Officer and Head of R&D

More info

Wim Souverijns, PhD

Chief Commercial Officer

More info

Board of Directors

Frank Verwiel, MD

Member
Chairperson, ObsEva Board of Directors

More info

Ernest Loumaye, MD, PhD

Co-Founder & CEO – ObsEvaMember, ObsEva Board of Directors

More info

Annette Clancy, BSc (Hons)

Member
ObsEva Board of Directors

More info

Barbara Duncan

Audit Committee Chair
ObsEva Board of Directors

More info

James I. Healy, MD, PhD

General Partner, Sofinnova Investments (U.S.A.)Member, ObsEva Board of Directors

More info

Ed Mathers

Partner, NEA (U.S.A.)Member, ObsEva Board of Directors

More info

Rafaèle Tordjman, MD, PhD

Member
ObsEva Board of Directors

More info

Jacky Vonderscher, PhD

MemberObsEva
Board of Directors

More info

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue